Accretive Health, Inc. (AH) Reports In-Line Q1 EPS, Reaffirm FY11 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts AH Hot Sheet
Join SI Premium – FREE
Accretive Health, Inc. (NYSE: AH) reported Q1 adjusted EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $163.7 million versus the consensus estimate of $168.41 million.
Accretive Health, Inc. sees FY2011 EPS of $0.42-$0.45, versus the consensus of $0.45.
Accretive Health, Inc. sees FY2011 EPS of $0.42-$0.45, versus the consensus of $0.45.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c
- Nike (NKE) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
